Global Non-Animal Alternatives Testing Market Research Report 2021 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Non-Animal Alternatives Testing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

The global non-animal alternatives testing market is expected to grow from $1.11 billion in 2020 to $1.23 billion in 2021 at a compound annual growth rate (CAGR) of 10.8%. The market is expected to reach $1.8 billion in 2025 at a CAGR of 10%.

Major players in the non-animal alternatives testing market are HRel Corporation, Cyprotex, VITROCELL, SIMULAB, Bio-Rad Laboratories, GE Healthcare, SGS SA, BioIVT, Abbott Laboratories and Gentronix Limited.

The non-animal alternatives testing market consists of sales of non-animal alternatives testing products and services that do not involve the use of animals for tests to determine the safety standards for products. The non-animal alternatives testing market involves testing for drugs, cosmetic products using non- animal testing methods. Organs-on-chip, In-vitro test, In-silico test are some examples of techniques and methodologies used as an alternative to animal testing.

The non-animal alternative testing market covered in this report is segmented by technology into cell culture technology, high throughput technology, molecular imaging, omics technology. It is also segmented by method into cellular assay, biochemical assay, in silico, ex-vivo and by end-user into pharmaceutical industry, cosmetics & household products, diagnostics, chemicals industry, food industry.

Compulsory animal testing is required for the approval of sale of various products such as the pesticides, industrial chemicals, drugs, medical devices, vaccines, genetically modified foods, and some consumer products. Animal testing is still a mandatory practice in some countries due to their legal system where any special use products, non- routine tests, imported cosmetic requires animal testing. The legal requirements in some countries for compulsory animal testing will hamper the growth of the market.

The support from the government and non-governmental organisations boosts the growth of the non-animal testing market. The government organisations enforces laws and regulations, raises funds to support the non-animal testing methods such as tests on human volunteers, advanced computer-modelling techniques and also funds studies with human volunteer. The constant support from the government drives the growth of the non-animal testing market.

The companies in the non-animal testing market are increasingly investing in technologies such as organs on the chip technology as an alternative to animal testing. Organs- on the- chip method contains human cells on a chip which mimics the structure and function of human organs and organs system instead of using of animal for the test.

Key Topics Covered:

1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Trends and Strategies

4. Impact Of COVID-19 On Non-Animal Alternatives Testing

5. Non-Animal Alternatives Testing Market Size and Growth

5.1. Global Non-Animal Alternatives Testing Historic Market, 2015-2020, $ Billion

5.1.1. Drivers Of the Market

5.1.2. Restraints On the Market

5.2. Global Non-Animal Alternatives Testing Forecast Market, 2020-2025F, 2030F, $ Billion

5.2.1. Drivers Of the Market

5.2.2. Restraints On the Market

6. Non-Animal Alternatives Testing Market Segmentation

6.1. Global Non-Animal Alternatives Testing Market, Segmentation by Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Cell Culture Technology
• High Throughput Technology
• Molecular Imaging
• Omics Technology

6.2. Global Non-Animal Alternatives Testing Market, Segmentation by Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Cellular Assay
• Biochemical Assay
• In Silico
• Ex-vivo

6.3. Global Non-Animal Alternatives Testing Market, Segmentation by End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

• Pharmaceutical Industry
• Cosmetics & Household Products
• Diagnostics
• Chemicals Industry
• Food Industry

7. Non-Animal Alternatives Testing Market Regional and Country Analysis

7.1. Global Non-Animal Alternatives Testing Market, Split by Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

7.2. Global Non-Animal Alternatives Testing Market, Split by Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

Companies Mentioned

• HRel Corporation
• Cyprotex
• VITROCELL
• SIMULAB
• Bio-Rad Laboratories
• GE Healthcare
• SGS SA
• BioIVT
• Abbott Laboratories
• Gentronix Limited
• Promega Corporation
• MB Research Laboratories
• Qiagen N.V.
• Urban Decay
• Catalent Inc.
• Evotec AG (Cyprotex plc)
• Catalent Inc
• Thermo Fisher Scientific
• Laboratory Corporation of America Holdings
• Charles River Laboratories Inc.
• Agilent Technologies Inc.
• BioReliance Corporation
• Ecco Bella
• Bare Blossom
• Billy Jealousy
• MuLondon Organic
• Modern Minerals Makeup
• BiomimX SRL
• Elveflow
• Emulate Inc.

For more information about this report visit https://www.researchandmarkets.com/r/9lctuz

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900